Table 2. Median numbers of essential medicines for cancer, from the World Health Organization’s Model Lists, on the national essential medicines lists or national reimbursable medicines lists of 135 countries, 2015.
| Country | Median no. listed (range) |
|
|---|---|---|
| Of 25 anti-cancer medicines on 2013 WHO Model List | Of 16 anti-cancer medicines added to WHO Model List via 2015 revision | |
| All (n = 135) | 17 (0–25) | 3 (0–15) |
| With national medicines list updated since 2012 (n = 41) | 18 (0–25) | 5 (0–15) |
| Income group | ||
| Low-income (n = 28) | 9 (0–23) | 1 (0–10) |
| Lower-middle-income (n = 44) | 18 (1–25) | 2 (0–14) |
| Upper-middle-income (n = 42) | 19 (0–25) | 7 (0–15) |
| High-income (n = 18) | 20 (8–25) | 10 (2–15) |
| WHO Region | ||
| Africa (n = 37) | 13 (1–23) | 1 (0–14) |
| Americas (n = 29) | 19 (3–25) | 6 (0–15) |
| South-East Asia (n = 11) | 21 (2–24) | 1 (0–13) |
| Europe (n = 26) | 18.5 (1–25) | 10 (0–15) |
| Eastern Mediterranean (n = 14) | 23.5 (0–25) | 6.5 (0–15) |
| Western Pacific (n = 18) | 7 (0–25) | 0.5 (0–15) |
| Western Pacific (n = 9)a | 19 (9–25) | 2 (1–15) |
WHO: World Health Organization.
a Excluding nine Pacific Island countries: Cook Islands, Kiribati, Marshall Islands, Nauru, Niue, Palau, Tonga, Tuvalu and Vanuatu.